Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Garrett M. Frampton is active.

Publication


Featured researches published by Garrett M. Frampton.


Proceedings of the National Academy of Sciences of the United States of America | 2010

Histone H3K27ac separates active from poised enhancers and predicts developmental state

Menno P. Creyghton; Albert W. Cheng; G. Grant Welstead; Tristan Kooistra; Bryce W. Carey; Eveline J. Steine; Jacob Hanna; Michael A. Lodato; Garrett M. Frampton; Phillip A. Sharp; Laurie A. Boyer; Richard A. Young; Rudolf Jaenisch

Developmental programs are controlled by transcription factors and chromatin regulators, which maintain specific gene expression programs through epigenetic modification of the genome. These regulatory events at enhancers contribute to the specific gene expression programs that determine cell state and the potential for differentiation into new cell types. Although enhancer elements are known to be associated with certain histone modifications and transcription factors, the relationship of these modifications to gene expression and developmental state has not been clearly defined. Here we interrogate the epigenetic landscape of enhancer elements in embryonic stem cells and several adult tissues in the mouse. We find that histone H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1 alone. This indicates that the amount of actively used enhancers is lower than previously anticipated. Furthermore, poised enhancer networks provide clues to unrealized developmental programs. Finally, we show that enhancers are reset during nuclear reprogramming.


Cell | 2008

Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells

Alexander Marson; Stuart S. Levine; Megan F. Cole; Garrett M. Frampton; Tobias Brambrink; Sarah E. Johnstone; Matthew G. Guenther; Wendy K. Johnston; Marius Wernig; Jamie J. Newman; J. Mauro Calabrese; Lucas M. Dennis; Thomas L. Volkert; Sumeet Gupta; Jennifer Love; Nancy M. Hannett; Phillip A. Sharp; David P. Bartel; Rudolf Jaenisch; Richard A. Young

MicroRNAs (miRNAs) are crucial for normal embryonic stem (ES) cell self-renewal and cellular differentiation, but how miRNA gene expression is controlled by the key transcriptional regulators of ES cells has not been established. We describe here the transcriptional regulatory circuitry of ES cells that incorporates protein-coding and miRNA genes based on high-resolution ChIP-seq data, systematic identification of miRNA promoters, and quantitative sequencing of short transcripts in multiple cell types. We find that the key ES cell transcription factors are associated with promoters for miRNAs that are preferentially expressed in ES cells and with promoters for a set of silent miRNA genes. This silent set of miRNA genes is co-occupied by Polycomb group proteins in ES cells and shows tissue-specific expression in differentiated cells. These data reveal how key ES cell transcription factors promote the ES cell miRNA expression program and integrate miRNAs into the regulatory circuitry controlling ES cell identity.


Nature | 2007

Foxp3 occupancy and regulation of key target genes during T-cell stimulation.

Alexander Marson; Karsten Kretschmer; Garrett M. Frampton; Elizabeth S. Jacobsen; Julia K. Polansky; Kenzie D. MacIsaac; Stuart S. Levine; Ernest Fraenkel; Harald von Boehmer; Richard A. Young

Foxp3+CD4+CD25+ regulatory T (Treg) cells are essential for the prevention of autoimmunity. Treg cells have an attenuated cytokine response to T-cell receptor stimulation, and can suppress the proliferation and effector function of neighbouring T cells. The forkhead transcription factor Foxp3 (forkhead box P3) is selectively expressed in Treg cells, is required for Treg development and function, and is sufficient to induce a Treg phenotype in conventional CD4+CD25- T cells. Mutations in Foxp3 cause severe, multi-organ autoimmunity in both human and mouse. FOXP3 can cooperate in a DNA-binding complex with NFAT (nuclear factor of activated T cells) to regulate the transcription of several known target genes. However, the global set of genes regulated directly by Foxp3 is not known and consequently, how this transcription factor controls the gene expression programme for Treg function is not understood. Here we identify Foxp3 target genes and report that many of these are key modulators of T-cell activation and function. Remarkably, the predominant, although not exclusive, effect of Foxp3 occupancy is to suppress the activation of target genes on T-cell stimulation. Foxp3 suppression of its targets appears to be crucial for the normal function of Treg cells, because overactive variants of some target genes are known to be associated with autoimmune disease.


Cell | 2011

Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis

Noa Novershtern; Aravind Subramanian; Lee N. Lawton; Raymond H. Mak; W. Nicholas Haining; Marie McConkey; Naomi Habib; Nir Yosef; Cindy Y. Chang; Tal Shay; Garrett M. Frampton; Adam Drake; Ilya B. Leskov; Björn Nilsson; Fred Preffer; David Dombkowski; John W. Evans; Ted Liefeld; John S. Smutko; Jianzhu Chen; Nir Friedman; Richard A. Young; Todd R. Golub; Aviv Regev; Benjamin L. Ebert

Though many individual transcription factors are known to regulate hematopoietic differentiation, major aspects of the global architecture of hematopoiesis remain unknown. Here, we profiled gene expression in 38 distinct purified populations of human hematopoietic cells and used probabilistic models of gene expression and analysis of cis-elements in gene promoters to decipher the general organization of their regulatory circuitry. We identified modules of highly coexpressed genes, some of which are restricted to a single lineage but most of which are expressed at variable levels across multiple lineages. We found densely interconnected cis-regulatory circuits and a large number of transcription factors that are differentially expressed across hematopoietic states. These findings suggest a more complex regulatory system for hematopoiesis than previously assumed.


Cell Stem Cell | 2010

Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells

Matthew G. Guenther; Garrett M. Frampton; Frank Soldner; Dirk Hockemeyer; Maya Mitalipova; Rudolf Jaenisch; Richard A. Young

Knowledge of both the global chromatin structure and the gene expression programs of human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) should provide a robust means to assess whether the genomes of these cells have similar pluripotent states. Recent studies have suggested that ESCs and iPSCs represent different pluripotent states with substantially different gene expression profiles. We describe here a comparison of global chromatin structure and gene expression data for a panel of human ESCs and iPSCs. Genome-wide maps of nucleosomes with histone H3K4me3 and H3K27me3 modifications indicate that there is little difference between ESCs and iPSCs with respect to these marks. Gene expression profiles confirm that the transcriptional programs of ESCs and iPSCs show very few consistent differences. Although some variation in chromatin structure and gene expression was observed in these cell lines, these variations did not serve to distinguish ESCs from iPSCs.


Nature | 2012

Enhancer decommissioning by LSD1 during embryonic stem cell differentiation

Warren A. Whyte; Steve Bilodeau; David A. Orlando; Heather A. Hoke; Garrett M. Frampton; Charles T. Foster; Shaun M. Cowley; Richard A. Young

Transcription factors and chromatin modifiers are important in the programming and reprogramming of cellular states during development. Transcription factors bind to enhancer elements and recruit coactivators and chromatin-modifying enzymes to facilitate transcription initiation. During differentiation a subset of these enhancers must be silenced, but the mechanisms underlying enhancer silencing are poorly understood. Here we show that the histone demethylase lysine-specific demethylase 1 (LSD1; ref. 5), which demethylates histone H3 on Lys 4 or Lys 9 (H3K4/K9), is essential in decommissioning enhancers during the differentiation of mouse embryonic stem cells (ESCs). LSD1 occupies enhancers of active genes that are critical for control of the state of ESCs. However, LSD1 is not essential for the maintenance of ESC identity. Instead, ESCs lacking LSD1 activity fail to differentiate fully, and ESC-specific enhancers fail to undergo the histone demethylation events associated with differentiation. At active enhancers, LSD1 is a component of the NuRD (nucleosome remodelling and histone deacetylase) complex, which contains additional subunits that are necessary for ESC differentiation. We propose that the LSD1–NuRD complex decommissions enhancers of the pluripotency program during differentiation, which is essential for the complete shutdown of the ESC gene expression program and the transition to new cell states.


Cell | 2010

Derivation of Pre-X Inactivation Human Embryonic Stem Cells under Physiological Oxygen Concentrations

Christopher J. Lengner; Alexander A. Gimelbrant; Jennifer A. Erwin; Albert W. Cheng; Matthew G. Guenther; G. Grant Welstead; Raaji K. Alagappan; Garrett M. Frampton; Ping Xu; Julien Muffat; Sandro Santagata; Doug Powers; C. Brent Barrett; Richard A. Young; Jeannie T. Lee; Rudolf Jaenisch; Maisam Mitalipova

The presence of two active X chromosomes (XaXa) is a hallmark of the ground state of pluripotency specific to murine embryonic stem cells (ESCs). Human ESCs (hESCs) invariably exhibit signs of X chromosome inactivation (XCI) and are considered developmentally more advanced than their murine counterparts. We describe the establishment of XaXa hESCs derived under physiological oxygen concentrations. Using these cell lines, we demonstrate that (1) differentiation of hESCs induces random XCI in a manner similar to murine ESCs, (2) chronic exposure to atmospheric oxygen is sufficient to induce irreversible XCI with minor changes of the transcriptome, (3) the Xa exhibits heavy methylation of the XIST promoter region, and (4) XCI is associated with demethylation and transcriptional activation of XIST along with H3K27-me3 deposition across the Xi. These findings indicate that the human blastocyst contains pre-X-inactivation cells and that this state is preserved in vitro through culture under physiological oxygen.


Genes & Development | 2008

Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia

Matthew G. Guenther; Lee N. Lawton; Tatiana Rozovskaia; Garrett M. Frampton; Stuart S. Levine; Thomas L. Volkert; Carlo M. Croce; Tatsuya Nakamura; Eli Canaani; Richard A. Young

Mixed-lineage leukemia (MLL) fusion proteins are potent inducers of leukemia, but how these proteins generate aberrant gene expression programs is poorly understood. Here we show that the MLL-AF4 fusion protein occupies developmental regulatory genes important for hematopoietic stem cell identity and self-renewal in human leukemia cells. These MLL-AF4-bound regions have grossly altered chromatin structure, with histone modifications catalyzed by trithorax group proteins and DOT1 extending across large domains. Our results define direct targets of the MLL fusion protein, reveal the global role of epigenetic misregulation in leukemia, and identify new targets for therapeutic intervention in cancer.


Nature | 2010

Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen

Frédéric Bienvenu; Siwanon Jirawatnotai; Joshua E. Elias; Clifford A. Meyer; Karolina Mizeracka; Alexander Marson; Garrett M. Frampton; Megan F. Cole; Duncan T. Odom; Junko Odajima; Yan Geng; Agnieszka Zagozdzon; Marie Jecrois; Richard A. Young; X. Shirley Liu; Constance L. Cepko; Steven P. Gygi; Piotr Sicinski

Cyclin D1 belongs to the core cell cycle machinery, and it is frequently overexpressed in human cancers. The full repertoire of cyclin D1 functions in normal development and oncogenesis is unclear at present. Here we developed Flag- and haemagglutinin-tagged cyclin D1 knock-in mouse strains that allowed a high-throughput mass spectrometry approach to search for cyclin D1-binding proteins in different mouse organs. In addition to cell cycle partners, we observed several proteins involved in transcription. Genome-wide location analyses (chromatin immunoprecipitation coupled to DNA microarray; ChIP-chip) showed that during mouse development cyclin D1 occupies promoters of abundantly expressed genes. In particular, we found that in developing mouse retinas—an organ that critically requires cyclin D1 function—cyclin D1 binds the upstream regulatory region of the Notch1 gene, where it serves to recruit CREB binding protein (CBP) histone acetyltransferase. Genetic ablation of cyclin D1 resulted in decreased CBP recruitment, decreased histone acetylation of the Notch1 promoter region, and led to decreased levels of the Notch1 transcript and protein in cyclin D1-null (Ccnd1-/-) retinas. Transduction of an activated allele of Notch1 into Ccnd1-/- retinas increased proliferation of retinal progenitor cells, indicating that upregulation of Notch1 signalling alleviates the phenotype of cyclin D1-deficiency. These studies show that in addition to its well-established cell cycle roles, cyclin D1 has an in vivo transcriptional function in mouse development. Our approach, which we term ‘genetic–proteomic’, can be used to study the in vivo function of essentially any protein.


Genes & Development | 2010

Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells

Marion Dejosez; Stuart S. Levine; Garrett M. Frampton; Warren A. Whyte; Sabrina A. Stratton; Michelle Craig Barton; Preethi H. Gunaratne; Richard A. Young; Thomas P. Zwaka

Self-renewing embryonic stem (ES) cells have an exceptional need for timely biomass production, yet the transcriptional control mechanisms responsible for meeting this requirement are largely unknown. We report here that Ronin (Thap11), which is essential for the self-renewal of ES cells, binds with its transcriptional coregulator, Hcf-1, to a highly conserved enhancer element that previously lacked a recognized binding factor. The subset of genes bound by Ronin/Hcf-1 function primarily in transcription initiation, mRNA splicing, and cell metabolism; genes involved in cell signaling and cell development are conspicuously underrepresented in this target gene repertoire. Although Ronin/Hcf-1 represses the expression of some target genes, its activity at promoter sites more often leads to the up-regulation of genes essential to protein biosynthesis and energy production. We propose that Ronin/Hcf-1 controls a genetic program that contributes to the unimpeded growth of ES cells.

Collaboration


Dive into the Garrett M. Frampton's collaboration.

Top Co-Authors

Avatar

Richard A. Young

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Matthew G. Guenther

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David A. Orlando

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Rudolf Jaenisch

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Stuart S. Levine

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Albert W. Cheng

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Megan F. Cole

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Steve Bilodeau

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Warren A. Whyte

Massachusetts Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge